A Case of Mixed Connective Tissue Disease Complicated by Pulmonary Hypertension and Ascites After Addition of Pulmonary Vasodilators

被引:0
作者
Kusaka, Katsuhide [1 ]
Nakano, Kazuhisa [1 ,2 ]
Fukuyo, Shunsuke [1 ]
Miyazaki, Yusuke [1 ]
Matsunaga, Satsuki [1 ]
Tanaka, Yoshiya [1 ]
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka, Japan
[2] Kawasaki Med Sch, Dept Rheumatol, Kawasaki, Kanagawa, Japan
关键词
mixed connective tissue disease; pulmonary arterial hypertension; ascites; systemic lupus erythematosus; systemic sclerosis; ARTERIAL-HYPERTENSION; SYSTEMIC-SCLEROSIS;
D O I
10.1093/mrcr/rxac019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present the case of a 54-year-old woman with a long history of pulmonary hypertension (PH) associated with mixed connective tissue disease (MCTD). She was being treated with pulmonary vasodilators, including epoprostenol and bosetan, but her mean pulmonary arterial pressure (mPAP) gradually worsened. Although her mPAP began to improve with adding sildenafil, ascites occurred. Discontinuing newly initiated drugs and starting diuretics improved her ascites. This suggested that an intensification of the treatment with vasodilators might have led to ascites (on a background of a probable arteriovenous shunt formation) in this patient with a long history of PH.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 8 条
[1]   Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases [J].
Dorfmueller, Peter ;
Humbert, Marc ;
Perros, Frederic ;
Sanchez, Olivier ;
Simonneau, Gerald ;
Mueller, Klaus-Michael ;
Capron, Frederique .
HUMAN PATHOLOGY, 2007, 38 (06) :893-902
[2]   Systemic sclerosis - A systematic overview Part 1-Disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance [J].
Klein-Weigel, P. ;
Opitz, C. ;
Riemekasten, G. .
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2011, 40 (01) :6-19
[3]   Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension [J].
Nakamura, Kazufumi ;
Sakaguchi, Masakiyo ;
Matsubara, Hiromi ;
Akagi, Satoshi ;
Sarashina, Toshihiro ;
Ejiri, Kentaro ;
Akazawa, Kaoru ;
Kondo, Megumi ;
Nakagawa, Koji ;
Yoshida, Masashi ;
Miyoshi, Toru ;
Ogo, Takeshi ;
Oto, Takahiro ;
Toyooka, Shinichi ;
Higashimoto, Yuichiro ;
Fukami, Kei ;
Ito, Hiroshi .
PLOS ONE, 2018, 13 (09)
[4]   Long-term patient survival with idiopathic/heritable pulmonary arterial hypertension treated at a single center in Japan [J].
Ogawa, Aiko ;
Ejiri, Kentaro ;
Matsubara, Hiromi .
LIFE SCIENCES, 2014, 118 (02) :414-419
[5]   Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy [J].
Overbeek, M. J. ;
Vonk, M. C. ;
Boonstra, A. ;
Voskuyl, A. E. ;
Vonk-Noordegraaf, A. ;
Smit, E. F. ;
Dijkmans, B. A. C. ;
Postmus, P. E. ;
Mooi, W. J. ;
Heijdra, Y. ;
Gruenberg, K. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (02) :371-379
[6]   Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis [J].
Ryerson, Christopher J. ;
Nayar, Shalini ;
Swiston, John R. ;
Sin, Don D. .
RESPIRATORY RESEARCH, 2010, 11
[7]   Epoprostenol infusion therapy changes angiographic findings of pulmonary arteries in patients with idiopathic pulmonary arterial hypertension [J].
Sakuma, Masahito ;
Demachi, Jun ;
Nawata, Jun ;
Suzuki, Jun ;
Takahashi, Tohru ;
Matsubara, Hiromi ;
Akagi, Satoshi ;
Shirato, Kunio .
CIRCULATION JOURNAL, 2008, 72 (07) :1147-1151
[8]  
Tanaka Yoshihito, 2020, Medicines (Basel), V7, DOI [10.3390/medicines7080046, 10.3390/medicines7080046]